The COVID-19 crisis has renewed our awareness of the significance of infectious disease preparedness research. It has created many challenges, but it has also provided chances for Institut Pasteur Korea to leap forward towards a global centre of excellence. The institute successfully discovered COVID-19 therapeutic candidates by drug repositioning. The platforms developed through these efforts will facilitate research and development on future emerging infectious diseases.
The greatest advantage of Institut Pasteur Korea is that it is part of a renowned Pasteur Network of health research institutes. Institut Pasteur Korea can capitalize on both the availability of cooperative resources deriving from this international network and Korea’s excellent research infrastructure in developing itself into an Asia-Pacific regional hub of infectious disease research and a global partner to major international public health bodies. Devoted researchers and employees are doing their best to usher Institut Pasteur Korea into a new stage of service to global health.
Youngmee JEE, MD, PhD
CEO of Institut Pasteur Korea